How Angiopoietin‑TEK signaling affects polypoidal choroidal vasculopathy (PCV)
The role of Angiopoietin-TEK signaling in polypoidal choroidal vasculopathy
Researchers are looking at how Angiopoietin‑TEK signaling contributes to PCV in adults, with attention to people of Asian and African ancestry.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11094761 on NIH RePORTER |
What this research studies
From a patient perspective, the team is exploring why a form of wet age‑related macular degeneration called polypoidal choroidal vasculopathy (PCV) forms dilated choroidal vessels and aneurysmal polyps. They will combine genetic information and laboratory experiments to learn how ANGPT/TEK pathway changes alter blood vessels beneath the retina. The work focuses on adults with PCV and pachychoroid features and draws on prior genetic links seen in people of Asian and African descent. Findings may come from analysis of patient-derived samples and experimental models to pinpoint molecular steps that could be targeted by new treatments.
Who could benefit from this research
Good fit: Ideal candidates are adults (21+) with polypoidal choroidal vasculopathy or pachychoroid‑related exudative AMD, particularly people of Asian or African ancestry.
Not a fit: People with dry (atrophic) AMD, unrelated eye conditions, or patients under 21 are unlikely to benefit directly from this research.
Why it matters
Potential benefit: If successful, this work could identify new treatment targets for PCV that help patients who respond poorly to current anti‑VEGF injections.
How similar studies have performed: Previous genetic studies have linked Angiopoietin‑TEK genes to PCV, but direct therapies targeting this pathway remain experimental and not yet proven in patients.
Where this research is happening
Chicago, United States
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Thomson, Benjamin R. — Northwestern University
- Study coordinator: Thomson, Benjamin R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.